BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 23378344)

  • 41. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.
    He Y; Xie H; Yu P; Jiang S; Wei L
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1049-1059. PubMed ID: 30302523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
    Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
    Han M; Liu M; Wang Y; Chen X; Xu J; Sun Y; Zhao L; Qu H; Fan Y; Wu C
    PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Forkhead Box Protein C2 Inhibitor: Targeting Epithelial-Mesenchymal Transition and Cancer Metastasis.
    Castaneda M; Chen L; Pradhan L; Li S; Zein R; Lee Y; Lim HS; Nam HJ; Lee J
    Chembiochem; 2018 Jul; 19(13):1359-1364. PubMed ID: 29577543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
    Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
    Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.
    Ilmer M; Mazurek N; Gilcrease MZ; Byrd JC; Woodward WA; Buchholz TA; Acklin K; Ramirez K; Hafley M; Alt E; Vykoukal J; Bresalier RS
    Breast Cancer Res; 2016 Sep; 18(1):97. PubMed ID: 27687248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
    Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
    Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells.
    Thrasyvoulou S; Vartholomatos G; Markopoulos G; Noutsopoulos D; Mantziou S; Gkartziou F; Papageorgis P; Charchanti A; Kouklis P; Constantinou AI; Tzavaras T
    Oncol Rep; 2020 Jul; 44(1):126-138. PubMed ID: 32377731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
    Xie G; Ji A; Yuan Q; Jin Z; Yuan Y; Ren C; Guo Z; Yao Q; Yang K; Lin X; Chen L
    Br J Cancer; 2014 May; 110(10):2514-23. PubMed ID: 24755887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A.
    Reisenauer KN; Tao Y; Das P; Song S; Svatek H; Patel SD; Mikhail S; Ingros A; Sheesley P; Masi M; Boari A; Evidente A; Kornienko A; Romo D; Taube J
    Sci Rep; 2021 May; 11(1):10652. PubMed ID: 34017048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm.
    Golden D; Cantley LG
    Oncogene; 2015 Sep; 34(36):4702-12. PubMed ID: 25486430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
    Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
    Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.
    Akella NM; Le Minh G; Ciraku L; Mukherjee A; Bacigalupa ZA; Mukhopadhyay D; Sodi VL; Reginato MJ
    Mol Cancer Res; 2020 Apr; 18(4):585-598. PubMed ID: 31974291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
    Li Y; Yang W; Yang Q; Zhou S
    Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition.
    Zhou Z; Zhang L; Xie B; Wang X; Yang X; Ding N; Zhang J; Liu Q; Tan G; Feng D; Sun LQ
    Cancer Lett; 2015 Jul; 363(2):137-45. PubMed ID: 25896630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.